Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/01/2007 | US20070254019 Method for treating brain cancer |
11/01/2007 | US20070254018 Method for site-specific application of topical medicants to aquatic animals |
11/01/2007 | US20070254017 Water soluble film, useful for packaging water treatment products such as sodium dichloroisocyanurate, made of a mixture of an acid stable polyvinyl alcohol; an oxidizable organic material; a chelating agent that is a phosphonic, phosphoric or aminopolycarboxylic acid; and a a free radical scavenger |
11/01/2007 | US20070254016 Biodegradable foam |
11/01/2007 | US20070254015 Sanitizing surfaces |
11/01/2007 | US20070254014 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same |
11/01/2007 | US20070254010 Methylene-containing copolymer of an unsaturated hydrocarbon monomer such as alpha-olefin, diolefin or cyclic olefin and an acrylic or vinyl monomer or having polyether, polylactone or polyester units; crosslinked with a radiation dose of at least 10,000 rads |
11/01/2007 | US20070254009 Antibiotic/bone morphogenic protein formulation and method of treatment |
11/01/2007 | US20070254008 Antibiotic formulation and method of treatment |
11/01/2007 | US20070254006 Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides |
11/01/2007 | US20070253989 Modified Powder and Cosmetic Composition Using the Same |
11/01/2007 | US20070253986 Method For Producing Multiple Emulsions That Are Stable In Storage |
11/01/2007 | US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin |
11/01/2007 | US20070253956 Method for opening tight junctions |
11/01/2007 | US20070253915 Methods for coating dental devices with dry-to-the-touch saliva soluble flavors |
11/01/2007 | US20070253913 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
11/01/2007 | US20070253912 Process for the preparation of micronised collagen, and its therapeutic applications |
11/01/2007 | US20070253911 Foamable compositions, kits and methods for hyperhidrosis |
11/01/2007 | US20070253899 Dual Function Polymer Micelles |
11/01/2007 | US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate |
11/01/2007 | CA2825758A1 Colonic drug delivery formulation |
11/01/2007 | CA2652759A1 Nanoparticles for providing immune responses against infectious agents |
11/01/2007 | CA2650922A1 Pre-mixed, ready-to-use nicardipine compositions |
11/01/2007 | CA2650211A1 Asymmetric membranes for drug delivery devices |
11/01/2007 | CA2650033A1 Compositions and methods useful for treatment of respiratory illness |
11/01/2007 | CA2649900A1 Niosome-hydrogel drug delivery |
11/01/2007 | CA2649895A1 Stable hydroalcoholic oral spray formulations and methods |
11/01/2007 | CA2649630A1 Lipoplex formulations for specific delivery to vascular endothelium |
11/01/2007 | CA2649556A1 Pharmaceutical solution formulations for pressurised metered dose inhalers |
11/01/2007 | CA2649550A1 Polymeric masticatory masses for cosmetic products |
11/01/2007 | CA2649538A1 Buffering agents for biopharmaceutical formulations |
11/01/2007 | CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
11/01/2007 | CA2649514A1 Licorice polyphenol preparation |
11/01/2007 | CA2648939A1 Stable emulsion formulations |
11/01/2007 | CA2648854A1 Fluid container and airless fluid dispensing system |
11/01/2007 | CA2648658A1 Colonic drug delivery formulation |
11/01/2007 | CA2648578A1 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
11/01/2007 | CA2648553A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
11/01/2007 | CA2648495A1 Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
11/01/2007 | CA2648360A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
11/01/2007 | CA2648291A1 Swellable particles for drug delivery |
11/01/2007 | CA2647087A1 Paediatric amino acid solution for parenteral nutrition |
11/01/2007 | CA2646667A1 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
11/01/2007 | CA2646487A1 Bone graft composition |
11/01/2007 | CA2646446A1 Pharmaceutical compositions for promoting wound healing |
11/01/2007 | CA2646206A1 Transdermal delivery system comprising sufentanil and its analogues |
10/31/2007 | EP1849830A1 Finely divided composition containing poorly water soluble substance |
10/31/2007 | EP1849487A2 Film-forming compositions and methods |
10/31/2007 | EP1849481A1 Composition for external use |
10/31/2007 | EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin |
10/31/2007 | EP1849473A1 Chinese traditional medicine composition for treatment of avian influenza, method for preparation, and application thereof |
10/31/2007 | EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
10/31/2007 | EP1849466A2 Infusion fluid for dialysis patients |
10/31/2007 | EP1849464A1 Wound dressings |
10/31/2007 | EP1849463A2 Microbial cellulose materials for use in transdermal drug delivery systems, methods of manufacture and use |
10/31/2007 | EP1849462A2 A method of alleviating signs and symptons of Spasticity |
10/31/2007 | EP1849461A1 Process for manufacturing films |
10/31/2007 | EP1849460A2 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
10/31/2007 | EP1849459A1 Ezetimibe compositions |
10/31/2007 | EP1849451A1 Sheet structure with at least one coloured face |
10/31/2007 | EP1849434A1 Coating for stents |
10/31/2007 | EP1848794A2 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof |
10/31/2007 | EP1848751A1 Partly neutralised anionic (meth)acrylate copolymer |
10/31/2007 | EP1848722A1 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same |
10/31/2007 | EP1848541A2 Method and device for ophthalmic administration of active pharmaceutical ingredients |
10/31/2007 | EP1848464A1 Compositions and methods for multimodal imaging |
10/31/2007 | EP1848444A1 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
10/31/2007 | EP1848431A1 Liquid formulations for treatment of diseases or conditions |
10/31/2007 | EP1848419A2 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
10/31/2007 | EP1848412A2 Transdermal systems having control delivery system |
10/31/2007 | EP1848411A2 Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics |
10/31/2007 | EP1848410A1 Polymer particle delivery compositions and methods of use |
10/31/2007 | EP1848409A1 Propranolol formulations |
10/31/2007 | EP1848408A1 Propranolol formulations |
10/31/2007 | EP1848407A2 Oral pharmaceutical composition |
10/31/2007 | EP1848406A2 Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol |
10/31/2007 | EP1848404A2 Lipid carrier compositions with reduced polydispersity |
10/31/2007 | EP1848403A1 Topical bioadhesive formulations |
10/31/2007 | EP1848402A1 Rasagiline formulations of improved content uniformity |
10/31/2007 | EP1848400A1 Analgesic compositions |
10/31/2007 | EP1848399A1 A compressed chewing gum table |
10/31/2007 | EP1848398A1 Stabilization of viral compositions |
10/31/2007 | EP1848397A1 Composition containing chitosan for sustained drug release |
10/31/2007 | EP1848290A2 Compositions and methods for nutrition supplementation |
10/31/2007 | EP1848271A2 Treatment for topical use alleviating or inhibiting joint pain or muscle pain or musculoskeletal pain in a mammal |
10/31/2007 | EP1848270A2 Transmucosal administration of drug compositions for treating and preventing disorders in animals |
10/31/2007 | EP1771180B1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
10/31/2007 | EP1680446B1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
10/31/2007 | EP1551493B1 Minimally compliant, volume efficient piston for osmotic drug delivery systems |
10/31/2007 | EP1469941B1 Microparticles and methods for their production |
10/31/2007 | EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
10/31/2007 | EP1404331B1 Sustained release formulations of oxymorphone |
10/31/2007 | EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
10/31/2007 | EP1294802B1 Polysaccharide based gel |
10/31/2007 | EP1214054B1 Intranasal influenza virus vaccine |
10/31/2007 | EP1140198B1 Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs |
10/31/2007 | EP1078079B1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
10/31/2007 | DE60125750T2 Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir A pharmaceutical formulation comprising carrier beads made with an applied layer valaciclovir |
10/31/2007 | DE102006020035A1 Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen Preparation and use of poly (hydroxyethyl) chitin and poly (carboxymethyl) chitin-compounds |
10/31/2007 | CN200966773Y Osteoproliferation plaster for reducing pain |